These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 273754)

  • 1. Hepatorenal syndrome. Reversal with LeVeen shunt.
    Grosberg SJ; Wapnick S; Leveen H; Reddy AN
    N Y State J Med; 1978 Mar; 78(4):637-9. PubMed ID: 273754
    [No Abstract]   [Full Text] [Related]  

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt.
    Wapnick S; Grosberg S; Kinney M; Azzara V; LeVeen HH
    Arch Surg; 1978 May; 113(5):581-5. PubMed ID: 646616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.
    Kinney MJ; Schneider A; Wapnick S; Grosberg S; LeVeen H
    Nephron; 1979; 23(5):228-32. PubMed ID: 481657
    [No Abstract]   [Full Text] [Related]  

  • 5. Peritoneovenous shunting for ascites.
    Reinhardt GF; Stanley MM
    Surg Gynecol Obstet; 1977 Sep; 145(3):419-24. PubMed ID: 888064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatorenal syndrome: reversal by peritoneovenous shunt.
    Fullen WD
    Surgery; 1977 Sep; 82(3):337-41. PubMed ID: 888100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal recirculating ascites dialysis (EAD) in combined hepatic and renal failure.
    Feldman J; Adler AJ; Friedman EA; Berlyne GM
    Trans Am Soc Artif Intern Organs; 1981; 27():563-5. PubMed ID: 7331131
    [No Abstract]   [Full Text] [Related]  

  • 8. Sounding boards. The LeVeen shunt for ascites and hepatorenal syndrome.
    Epstein M
    N Engl J Med; 1980 Mar; 302(11):628-30. PubMed ID: 6986021
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hepato-renal syndrome. Therapeutic problems].
    Tufano R; Porcellini M; Zotti GC; Roberti Q; Santangelo ML
    Minerva Anestesiol; 1978; 44(1):57-58. PubMed ID: 643196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Nilius R
    Gastroenterol J; 1991; 51(3-4):97-102. PubMed ID: 1811663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
    Castells A; Saló J; Planas R; Quer JC; Ginès A; Boix J; Ginès P; Gassull MA; Terés J; Arroyo V
    Hepatology; 1994 Sep; 20(3):584-91. PubMed ID: 8076916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatorenal syndrome].
    Radziszewski A; Sułowicz W
    Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LaVeen continuous peritoneal-jugular shunt. Improvement of renal function in ascitic patients.
    Wapnick S; Grosberg S; Kinney M; LeVeen HH
    JAMA; 1977 Jan; 237(2):131-3. PubMed ID: 576150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ
    J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of liver cirrhosis. Managing complications with fingertip control].
    Mörk H
    MMW Fortschr Med; 2001 Jul; 143(26-27):34-7. PubMed ID: 11481913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of portal hypertension. Indications for and methods of portacaval shunt in the cirrhotic patient].
    Maillard JN; Flamant Y
    Minerva Med; 1978 Apr; 69(17):1167-70. PubMed ID: 662146
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of mortality in cirrhosis of the liver.
    Lecompte Y; Metreau JM; Sancho HS; Bismuth H
    Surg Gynecol Obstet; 1974 Oct; 139(4):529-30. PubMed ID: 4608304
    [No Abstract]   [Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.